It was a busy week for biotech investors as several players released earnings, for better or worse. Namely, all eyes were on Valeant …
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and MannKind Corporation (NASDAQ:MNKD) both know what it’s like to be the fan favorites in the biotech sector. …
The iShares Nasdaq Biotechnology ETF (IBB) ended 3.8 percent lower Tuesday, as investors reacted harshly toward poor earnings results by pharma giant Valeant Pharmaceuticals …
Linn Energy LLC (NASDAQ:LINE) is falling 29% in pre-market trading after the company posted disappointing Q4:15 revenues earlier this morning. The company reported …
Partnership terminations, government investigations, pipeline updates, and advancements in new products mark this week’s earnings reports from Valeant Pharmaceuticals Intl Inc (NYSE:VRX), MannKind Corporation …
MannKind Corporation Piper Jaffray analyst Joshua Schimmer weighed in on shares of MannKind Corporation (NASDAQ:MNKD) after the company’s founder passed away today at the age …
Analysts have mixed sentiments on MannKind Corporation (NASDAQ:MNKD) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). It’s a long fall from the top as MannKind investors …
Healthcare analysts weigh in today on insulin drug maker MannKind Corporation (NASDAQ:MNKD) and biotechnology company Conatus Pharmaceuticals Inc (NASDAQ:CNAT). While one analyst is quite bearish on MannKind …
MannKind Corporation On Thursday January 21, 2016 MannKind Corporation (NASDAQ:MNKD) had announced that it had entered into a license agreement, with a newly …
Concluding another successful year, the 2016 JP Morgan Healthcare Conference has seen its share of announcements, discoveries and unveiling of things to come. Among …
